Cases & Deals

  • Home
  • Practices
  • Seattle Genetics builds patent portfolio for antibodies and antibody-drug conjugates for cancer treatment

Share

Seattle Genetics builds patent portfolio for antibodies and antibody-drug conjugates for cancer treatment

February 2008

Client(s) Seattle Genetics, Inc.

Jones Day assisted with the portfolio development for Seattle Genetics, Inc. regarding its patent portfolio relating to antibodies and antibody-drug conjugates for treatment of cancer.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.